Lv11
50 积分 2026-04-10 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
1个月前
已完结
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial
1个月前
已完结
Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia
1个月前
已关闭
Safety and Efficacy of Combining Tagraxofusp (SL-401) with Azacitidine or Azacitidine and Venetoclax in a Phase 1b Study for CD123 Positive AML, MDS, or BPDCN
1个月前
已关闭
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Broad Activity for the Pivekimab Sunirine (PVEK, IMGN632), Azacitidine, and Venetoclax Triplet in High-Risk Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
1个月前
已关闭
皖公网安备34019202002308
